The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma

1

Introduction

00:00 • 2min

2

CDMO Capacity Crunch and CDMO Dynamics

01:35 • 2min

3

Gene Therapy

03:09 • 5min

4

What Is the Center for Breakthrough Medicines?

07:53 • 3min

5

The Complexity of the Demand for Advanced Therapy Manufacturing

11:07 • 3min

6

CDMO's and the Hybrid Model

13:51 • 5min

7

CDMO Outsourcing - What's the Difference?

18:29 • 4min

8

Biotech Accelerator - C Y T I v a Life Sciences

22:11 • 3min

9

What's the Quality of a CDMO?

24:49 • 2min

10

Is CDMO Aligned With Our Patient Focus Mission?

26:23 • 2min

11

CDMO - What Are the Risks?

28:03 • 4min

12

CDMO Selection Is the Most Critical Crucial Decision That Companies Are Making Right Now

31:56 • 4min

13

Are You Looking for a CDMO?

36:03 • 3min

14

What's the Ideal Partner for Gene Therapy?

39:26 • 4min

15

Do You Have a CDMO Partner?

43:24 • 2min

16

Are You Sticking With the CDMO?

45:33 • 2min